Recent advancements in cardiovascular risk assessment are increasingly highlighting the utility of coronary artery calcium (CAC) scans as a valuable tool for predicting an individual’s likelihood of experiencing heart disease in the future. This non-invasive computed tomography (CT) examination, characterized by its speed and affordability, quantifies the presence and extent of calcified plaque within the coronary arteries, which are the vital conduits supplying oxygenated blood to the heart muscle. While the adoption of CAC screening has been on the rise, novel research emanating from Northwestern Medicine suggests that the greatest clinical impact of this diagnostic modality may be concentrated within a more specific patient demographic than initially anticipated.
A comprehensive longitudinal study, meticulously tracking over 6,000 adults for a decade, revealed that for the general participant cohort, the integration of a CAC score offered only a marginal enhancement to the predictive accuracy of the PREVENT calculator, a widely recognized risk assessment tool developed by the American Heart Association. The PREVENT algorithm, designed to estimate the probability of developing cardiovascular disease over a 10- or 30-year timeframe, relies on readily available clinical data such as blood pressure readings, cholesterol levels, age, and sex. In contrast, the CAC scan adopts a direct anatomical approach, visually identifying and measuring calcified deposits within the coronary arteries. The resulting score serves as a quantitative indicator, with higher scores generally correlating with an elevated risk of future cardiovascular events.
The groundbreaking findings from the Northwestern Medicine investigation indicate that CAC scores demonstrate their most significant predictive power when an individual’s initial risk assessment, such as that provided by the PREVENT calculator, places them in a borderline or intermediate risk category. Within this specific subgroup of patients, the additional information gleaned from a CAC scan offered a more refined and definitive understanding of their future cardiovascular trajectory, clearly distinguishing those with a higher propensity for developing heart disease from those with a comparatively lower risk.
Dr. Nilay Shah, the senior author of the study and an assistant professor of medicine in the cardiology division at Northwestern University Feinberg School of Medicine, emphasized that while CAC scans are becoming more accessible and cost-effective, their routine application may not be universally beneficial for all individuals seeking to assess their risk of heart attack and stroke. He articulated that the research underscores the importance of judiciously applying these scans, particularly in scenarios where the results are unlikely to alter the course of patient management or treatment strategies.
Dr. Shah further elaborated on the potential drawbacks of widespread CAC screening. He noted that deploying this technology in individuals classified as low risk could lead to unnecessary exposure to ionizing radiation, incur avoidable testing expenses, and generate clinical benefits that are not clearly defined. Conversely, he suggested that for patients already identified as being at high risk, a CAC scan might prove to be redundant, as established guidelines often recommend initiating statin therapy for such individuals irrespective of their specific CAC score.
The detailed analysis underpinning these conclusions was published on August 26th in the esteemed medical journal JAMA. The research team’s methodology involved a thorough examination of data sourced from the Multi-Ethnic Study of Atherosclerosis (MESA), an extensive observational study that enrolled over 6,000 participants between the ages of 45 and 79 at the commencement of the investigation.
At the outset of the MESA study, each participant underwent both a CAC scoring procedure and an evaluation using the PREVENT calculator to ascertain their estimated 10-year risk of experiencing a cardiovascular event. The researchers then meticulously documented the actual health outcomes of these individuals over the subsequent decade. During this follow-up period, approximately 6% of the study cohort experienced either a heart attack or a stroke. When the predictive models incorporating CAC scores were compared against those relying solely on the PREVENT calculator, the overall improvement in predictive accuracy was observed to be modest. The model’s discriminative capacity, a measure of its ability to effectively differentiate between individuals who would and would not experience a cardiovascular event, saw only a slight increase, rising from 0.73 with PREVENT alone to 0.75 when CAC scores were integrated.
However, the analytical landscape shifted dramatically when the researchers narrowed their focus to individuals whose baseline PREVENT scores categorized them as being at borderline or intermediate risk, defined as an initial estimated risk of 3% to 9% for heart disease within a 10-year window. For this specific patient group, the inclusion of CAC score data yielded a substantially more meaningful enhancement in the precision of predicting future cardiovascular events. Dr. Shah explained that for patients situated in this intermediate risk stratum, knowledge of their CAC score could provide critical insights, helping to clarify whether their actual risk was lower or higher than initially estimated, thereby offering more precise guidance for therapeutic decision-making.
Cardiovascular disease remains the leading cause of mortality in the United States, affecting an estimated 10% of U.S. adults aged 30-79. Nevertheless, Dr. Shah highlighted that a significant proportion of heart attacks, strokes, and other cardiovascular incidents are preventable. The accurate identification of an individual’s risk profile is paramount in enabling clinicians to determine which patients are most likely to benefit from preventive interventions, such as statins, which are instrumental in lowering cholesterol levels and mitigating cardiovascular risk.
The study’s outcomes, according to Dr. Shah, offer valuable guidance on optimizing the application of existing risk assessment tools, thereby facilitating more precise recommendations for individuals who stand to gain the most from statin therapy to prevent heart disease. He also noted that the findings lend support to the clinical utility of the relatively new PREVENT calculator, which demonstrated robust performance in predicting cardiovascular risk even without the incorporation of CAC scan results.
Despite the significant contributions of this research, the investigators acknowledged that further studies are warranted to fully elucidate the extent to which CAC scores enhance PREVENT risk estimates across diverse patient populations. Dr. Shah specifically pointed to the need for more research in higher-risk ethnic groups, such as South Asian and Filipino adults, as well as in younger individuals, given that the current study’s participants were between 45 and 79 years old at its inception. Additional Northwestern co-authors contributing to this pivotal study include Xiaoning Huang, Lucia Petito, Norrina Allen, Dr. Philip Greenland, and Dr. Sadiya Khan. The research paper is titled, "Predictive Utility of Coronary Artery Calcium Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations," and received support from the American Heart Association and the National Heart, Lung, and Blood Institute through various grant and contract mechanisms.
About the Author
